Mechanisms of Maternal Immune Tolerance in Early Pregnancy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity Hospital, Basel, Switzerland
About this trial
This study explores the mechanisms of maternal immune tolerance in early pregnancy by characterizing immune cell profiles and functional pathways during the first trimester. The goal is to identify immunological factors that support healthy gestation and prevent complications such as miscarriages.
Eligibility criteria
Qualifiers
where the patient (pregnant person) was ≥ 18 years of age.
where the patient (pregnant person) signed a written informed consent.
Disqualifiers
Certain maternal infections (HIV, Hepatitis B, Hepatitis C, Syphilis)
Patients under immunosuppressive medications (at time of blood sample collection)
Trial design
Treatments tested in this trial
- Blood sampling
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov